Type a description of this image

News

Contact →
Type a description of this image

BRC-002 receives Orphan Drug Designation from FDA for Complex Regional Pain Syndrome

PR Newswire

Dec 4, 2024
Type a description of this image

Biopharmaceutical Research Company Announces First Dose of BRC-002, a First-in-Class Cannabinoid Therapeutic for Complex Regional Pain Syndrome (CRPS), in Investigator-Initiated Study

PR Newswire

Oct 4, 2024
Type a description of this image

City of Hope and Biopharmaceutical Research Company announce first patient has received BRC-001, a first-in-class cannabinoid therapeutic, in a clinical trial investigating supportive care in breast cancer

PR Newswire

Sep 13, 2024
Type a description of this image

QNTM Brings in New CEO to Drive Next Phase Commercial Growth

QNTM Labs

Mar 21, 2024
Type a description of this image

New Scientific Discoveries in CBD’s Ability to Reduce Pain and Inflammation

NextEvo Naturals

Mar 20, 2024
Type a description of this image

Nalu Bio and PIPA Bring Cannabinoid Combinations To CPG Brands in First-Of-Its-Kind Partnership Powered by AI

PR Newswire

Feb 9, 2024
Type a description of this image

Treez Reports Accelerated Growth and Product Innovation to Help Retailers Become Profitable in 2023 Results

GlobeNewswire

Feb 7, 2024
Type a description of this image

Treez and Metrc Partner to Create the First Ever Global Product Catalog for Cannabis

GlobeNewswire

Nov 28, 2023
Type a description of this image

RX Green Technologies Announces Appointment of Gary Santo as CEO

PR Newswire

Nov 8, 2023